Merck Animal Health agrees to acquire poultry tech innovator TARGAN
Merck Animal Health, a subsidiary of pharmaceutical giant Merck & Co (NYSE:MRK), signed a definitive agreement to acquire TARGAN, a privately held agtech developer specializing in high-speed automated biodevices for commercial hatcheries.




_1419358_640x360_2503294531503-640x360.webp&w=3840&q=75)
-640x360.webp&w=3840&q=75)

_1419350_640x360_2503289923900-640x360.webp&w=3840&q=75)



